MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder
Overview
This study protocol outlines a double-blind, randomized controlled trial investigating the safety, efficacy, and cost-effectiveness of MDMA-assisted integrated exposure therapy for individuals with comorbid PTSD and alcohol use disorder. The research compares outcomes between participants receiving MDMA alongside prolonged exposure therapy versus those receiving an active control (niacin) under similar conditions. The resource details the study design, including participant randomization, dosing regimens, and specific clinical measures for PTSD and drinking behaviors.
- ID
0b45c2b25f0e43d5- Source org
- PubMed Central
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.1136/bmjopen-2025-114896
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:0b45c2b25f0e43d5,
title = {MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder},
journal = {PubMed Central},
doi = {10.1136/bmjopen-2025-114896},
url = {https://doi.org/10.1136/bmjopen-2025-114896}
}RIS
TY - JOUR TI - MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder PB - PubMed Central DO - 10.1136/bmjopen-2025-114896 UR - https://doi.org/10.1136/bmjopen-2025-114896 ER -
APA
MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder. (n.d.). PubMed Central. https://doi.org/10.1136/bmjopen-2025-114896
Related entries
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
- Massed prolonged exposure for posttraumatic stress disorder among individuals in comprehensive substance use treatment: Study protocol for a randomized controlled trial
- Development of expert recommendations for the treatment of PTSD with comorbid substance use disorder
- Resting-state connectivity subtype of comorbid PTSD and alcohol use disorder moderates improvement from integrated prolonged exposure therapy in Veterans
- Intensive outpatient treatment for PTSD: an open trial combining prolonged exposure therapy, EMDR, and physical activity
- The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder
- Use of an Integrated Therapy With Prolonged Exposure to Treat PTSD and Comorbid Alcohol Dependence in an Iraq Veteran
- A systematic review and meta-analysis of psychological interventions for comorbid post-traumatic stress disorder and substance use disorder
- 12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity
- Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD